Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Some things just take time...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1502)
•••
Post by wildbird1on Feb 19, 2024 9:01am
788 Views
Post# 35887384

Some things just take time...

Some things just take time...Summary for the new people on this board....

Aug 29,2022          450 day CR%  =21%.
Nov 29,2022             ''           ''       =28%.
May10,2023             ''          ''         =30%.
Aug 29,2023            ''           ''        =33%.
Oct 16,2023             ''          ''         =34%(Optimized).
Nov 29,2023            ''          ''         =36%(Optimized).
Jan  15,2024           ''           ''         =39%(Optimized).

Big Pharma Deal....
If TLT get BTD in the second/third quarter of 2024 we could see a Big Pharma Deal before year end.

If you extrapolate with the above CR% numbers, you can easily assume that the CR% at 450 days in the third/fourth quarter of 2024 could be over 45%CR(Optimized).

A Big Pharma deal with a 25%CR% at 450 days could be worth $$$???million.
But a Big Pharma deal with a 45%CR at 450 days could be worth $100 of million more.

I agree the delays are unpleasant, but the reward could be worth it.

Warrent Buffet said '' No matter how great the talent or efforts, some things just take time''.







  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities